{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:14:15Z","timestamp":1764785655167,"version":"build-2065373602"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To identify the mutational signature(s) for patients with diagnosed chronic lymphocytic leukemia (CLL) and their correlation with clinical and genetic classifications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>All CLL samples sequenced on several versions of OncoPanel, from 2013 to 2022, were examined (n\u2005=\u2005209). All variants produced by the next-generation sequencing pipeline, before review, were obtained for these samples. After the exclusion of likely germline polymorphisms, mutational signatures were generated. De novo mutational signatures were extracted and correlated with clinical and genetic data.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Most somatic mutations were found in chromosome 14 (within ADAM6). Somatic mutation signatures analysis revealed a prominent endogenous mutational process, which predominantly led to C-to-T single base substitutions (SBSs). Two novel de novo SBS signatures were identified, weighted by the SBS84 signature, that correlated with somatically hypermutated and unmutated status, respectively, with significant disease heterogeneity. A notable 13.3% of the cohort exhibited the SBS42 signature, suggesting a link to occupational haloalkane exposure, representing a potential new environmental risk factor for CLL.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The de novo SBS signatures were identified as being associated with IGHV status, highlighting significant disease heterogeneity that belies the more categorical and limited traditional risk stratification methods. Also, a novel association was made between haloalkane exposure signature and CLL.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajcp\/aqaf059","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T07:54:42Z","timestamp":1755244482000},"page":"530-544","source":"Crossref","is-referenced-by-count":1,"title":["Mutational signature analysis of chronic lymphocytic leukemia uncovering genomic patterns and prognostic implications"],"prefix":"10.1093","volume":"164","author":[{"given":"Ali","family":"AlJabban","sequence":"first","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital , Boston, MA ,","place":["United States"]},{"name":"Harvard Medical School , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta S","family":"Azevedo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Antel","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Medical University of South Carolina , Charleston, SC ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Arnette","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth F","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Informatics and Analytics, Dana-Farber Cancer Institute , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7054-8624","authenticated-orcid":false,"given":"David M","family":"Meredith","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital , Boston, MA ,","place":["United States"]},{"name":"Harvard Medical School , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A","family":"Murakami","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, MA ,","place":["United States"]},{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynette M","family":"Sholl","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Y","family":"Tolstorukov","sequence":"additional","affiliation":[{"name":"Department of Informatics and Analytics, Dana-Farber Cancer Institute , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrison K","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital , Boston, MA ,","place":["United States"]},{"name":"Harvard Medical School , Boston, MA ,","place":["United States"]},{"name":"Department of Pathology, Boston Children\u2019s Hospital , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital , Boston, MA ,","place":["United States"]},{"name":"Harvard Medical School , Boston, MA ,","place":["United States"]},{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Zemmour","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Chicago , IL ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal I","family":"Lindeman","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weill Cornell Medicine , New York, NY ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Garcia","sequence":"additional","affiliation":[{"name":"Variantyx, Inc., Framingham , MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R","family":"Brown","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, MA ,","place":["United States"]},{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette S","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan , Ann Arbor, MI ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"key":"2025100407170653000_CIT0001","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.celrep.2012.12.008","article-title":"Deciphering signatures of mutational processes operative in human cancer","volume":"3","author":"Alexandrov","year":"2013","journal-title":"Cell Rep."},{"key":"2025100407170653000_CIT0002","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/carcin\/bgw066","article-title":"Hypermutation and unique mutational signatures of occupational cholangiocarcinoma in printing workers exposed to haloalkanes","volume":"37","author":"Mimaki","year":"2016","journal-title":"Carcinogenesis."},{"key":"2025100407170653000_CIT0003","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/php.12377","article-title":"signature mutations","volume":"91","author":"Brash","year":"2015","journal-title":"Photochem Photobiol."},{"key":"2025100407170653000_CIT0004","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature."},{"key":"2025100407170653000_CIT0005","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/path.5912","article-title":"An overview of mutational and copy number signatures in human cancer","volume":"257","author":"Steele","year":"2022","journal-title":"J Pathol."},{"key":"2025100407170653000_CIT0006","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/ng.3441","article-title":"Clock-like mutational processes in human somatic cells","volume":"47","author":"Alexandrov","year":"2015","journal-title":"Nat Genet."},{"key":"2025100407170653000_CIT0007","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature17676","article-title":"Landscape of somatic mutations in 560 breast cancer whole-genome sequences","volume":"534","author":"Nik-Zainal","year":"2016","journal-title":"Nature."},{"key":"2025100407170653000_CIT0008","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3389\/fcell.2020.00357","article-title":"Evaluation of somatic hypermutation status in chronic lymphocytic leukemia (CLL) in the era of next generation sequencing","volume":"8","author":"Gupta","year":"2020","journal-title":"Front Cell Dev Biol."},{"key":"2025100407170653000_CIT0009","doi-asserted-by":"publisher","first-page":"751","DOI":"10.5858\/arpa.2016-0527-OA","article-title":"Validation of OncoPanel: a targeted next-generation sequencing assay for the detection of somatic variants in cancer","volume":"141","author":"Garcia","year":"2017","journal-title":"Arch Pathol Lab Med."},{"key":"2025100407170653000_CIT0010"},{"key":"2025100407170653000_CIT0011","doi-asserted-by":"publisher","first-page":"100179","DOI":"10.1016\/j.xgen.2022.100179","article-title":"Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor","volume":"2","author":"Ashiqul Islam","year":"2022","journal-title":"Cell Genomics."},{"key":"2025100407170653000_CIT0012","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1186\/s12864-019-6041-2","article-title":"SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events","volume":"20","author":"Bergstrom","year":"2019","journal-title":"BMC Genomics."},{"key":"2025100407170653000_CIT0013","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood."},{"key":"2025100407170653000_CIT0014","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood."},{"key":"2025100407170653000_CIT0015","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/hon.3106","article-title":"Richter transformation in chronic lymphocytic leukemia","volume":"41","author":"Innocenti","year":"2023","journal-title":"Hematol Oncol."},{"key":"2025100407170653000_CIT0016","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1182\/blood-2018-09-873083","article-title":"Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact","volume":"133","author":"Baliakas","year":"2019","journal-title":"Blood."},{"key":"2025100407170653000_CIT0017","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1056\/NEJMoa023143","article-title":"ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia","volume":"348","author":"Crespo","year":"2003","journal-title":"N Engl J Med."},{"key":"2025100407170653000_CIT0018","doi-asserted-by":"publisher","first-page":"8866","DOI":"10.1038\/ncomms9866","article-title":"Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution","volume":"6","author":"Kasar","year":"2015","journal-title":"Nat Commun."},{"key":"2025100407170653000_CIT0019","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/carcin\/bgw066","article-title":"Hypermutation and unique mutational signatures of occupational cholangiocarcinoma in printing workers exposed to haloalkanes","volume":"37","author":"Mimaki","year":"2016","journal-title":"Carcinogenesis"},{"key":"2025100407170653000_CIT0020","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1745-6673-8-14","article-title":"Work-related leukemia: a systematic review","volume":"8","author":"Polychronakis","year":"2013","journal-title":"J Occup Med Toxicol"},{"key":"2025100407170653000_CIT0021","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1021\/acs.chemrestox.3c00358","article-title":"5-Chloro-2\u2032-deoxycytidine induces a distinctive high-resolution mutational spectrum of transition mutations in vivo","volume":"37","author":"Chancharoen","year":"2024","journal-title":"Chem Res Toxicol."},{"key":"2025100407170653000_CIT0022","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.200014.112","article-title":"Regulation of AID, the B-cell genome mutator","volume":"27","author":"Keim","year":"2013","journal-title":"Genes Dev."},{"key":"2025100407170653000_CIT0023","doi-asserted-by":"publisher","first-page":"e1157667","DOI":"10.1080\/23723556.2016.1157667","article-title":"Mutational landscape and underlying mutational processes in chronic lymphocytic leukemia","volume":"3","author":"Kasar","year":"2016","journal-title":"Mol Cell Oncol."},{"key":"2025100407170653000_CIT0024","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1038\/s41467-019-11037-8","article-title":"A practical guide for mutational signature analysis in hematological malignancies","volume":"10","author":"Maura","year":"2019","journal-title":"Nat Commun."},{"key":"2025100407170653000_CIT0025","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/cam4.3586","article-title":"Pigmentary traits, sun exposure, and risk of non-Hodgkin\u2019s lymphoma\/chronic lymphocytic leukemia: a study within the French E3N prospective cohort","volume":"10","author":"Garcin","year":"2021","journal-title":"Cancer Med."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/164\/4\/530\/64055106\/aqaf059.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/164\/4\/530\/64055106\/aqaf059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T11:17:12Z","timestamp":1759576632000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/164\/4\/530\/8235669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8,15]]},"published-print":{"date-parts":[[2025,10,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqaf059","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"type":"print","value":"0002-9173"},{"type":"electronic","value":"1943-7722"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,8,15]]}}}